A defined subunit vaccine that protects against vector-borne visceral leishmaniasis

A defined subunit vaccine that protects against vector-borne visceral leishmaniasis

Leishmaniasis: Improved vaccine candidate demonstrates protection A research collaboration between the United States and Bangladesh has improved its own vaccine candidate and demonstrated it to be effective. The vaccine’s target, visceral leishmaniasis, is a deadly parasitic disease transmitted via...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Malcolm S. Duthie, Lais Pereira, Michelle Favila, Kimberly A. Hofmeyer, S. Jim Reed, Sonia Metangmo, Shannon Townsend, John D. Laurance, Alessandro Picone, Ayesha Misquith, Faria Hossain, Prakash Ghosh, Md Anik Ashfaq Khan, Jeffery Guderian, H. Remy Bailor, Hong Liang, Julie Vergara, Fabiano Oliveira, Randall F. Howard, Shaden Kamhawi, Dinesh Mondal, Rhea N. Coler, Jesus G. Valenzuela, Steven G. Reed
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
Immunologic diseases. Allergy
RC581-607
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Acceso en línea:https://doaj.org/article/1521212ea78c4b1fba37c36cea70ce62
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares